PRP Hair Treatment Candidates and Who Should Avoid It
Who is a good candidate for PRP hair treatment and who should avoid it?
The honest answer turns on one question: is there still living hair in the area that bothers you? This treatment thickens and holds onto follicles that are shrinking, so it rewards you for starting while there's something left to save, and it does nothing at all for skin that's already gone smooth. Your general health and your expectations decide the rest.
The strongest candidate has visible thinning of relatively recent onset with fine or short hairs still present in the affected zone, a normal platelet count, and no bleeding or clotting disorder.
What patterns of hair loss respond best to platelet-rich plasma injections?
Not every kind of thinning behaves the same way under a needle. Inherited pattern loss responds best because the follicle isn't dead, it's miniaturising, still cycling and still able to answer a growth signal. That one biological fact sorts almost every case you'll come across.
Androgenetic hair loss carries the most supporting evidence behind it, and response is judged over three to six months against baseline photographs and hair counts in a fixed area rather than by impression.
At what stage of thinning is it too late for the treatment to help?
There's no calendar cut-off here, which is what trips most people up. What decides it is whether living follicular units are still sitting in the area you want treated, and a magnified scalp view answers that in about a minute. If you're at the later end, the honest framing is holding the line, not growing it back.
| What gets checked | Still inside the window | Past the window |
|---|---|---|
| Bare skin | Pores visible, some fine hair | Smooth, slightly shiny, no pores |
| Under magnification | Mixed shaft thickness, open ostia | Uniform, closed openings |
| Grading stage | Early to middle | Upper male stages, most advanced female stage |
| Honest goal | Thicker, denser existing hair | Preservation in the fringe zone only |
Once the dermal papilla at the base of the follicle is lost and the opening has closed over, there's nothing for growth factors to act on, which puts the upper stages of the male scale and the most advanced stage of the female scale outside the treatable window.
Do age and sex change how well someone responds?
Age matters, but not the way you'd assume. It's less about your number and more about how long the loss has been running and how briskly your body still repairs itself. Sex shifts the picture too, though it does it through the driver behind the loss rather than through the response itself.
- Ideal profile: late twenties to thirties, with thinning that started around two years ago.
- Regenerative response: softens with age, so at sixty you'll see a smaller, slower gain than at thirty with the same pattern.
- Female work-up: thyroid, iron and the shift around menopause are common contributors, so bloods come before booking.
- Under twenty-one with an aggressive family pattern: usually steered to a medical treatment first rather than an indefinite injection schedule.
There's no hard upper age limit, but a woman presenting with thinning deserves a blood work-up before anyone books a session, since a correctable cause such as thyroid disease or iron deficiency changes the whole plan.
Which medical conditions make the treatment unsafe or ineffective?
Exclusions come in two tiers, and mixing them up is how people end up either treated unsafely or turned away for no good reason. One tier is short and firm. The other is a judgement call, and you should hear it made out loud rather than assumed.
Absolute exclusions are platelet dysfunction, critically low platelet counts, active haematological cancer, metastatic disease, current sepsis, and anticoagulant therapy that can't be safely interrupted.
Which medications and supplements interfere with platelet activity before a session?
This is the one that quietly wastes sessions, and it's usually something you bought without a prescription and forgot to mention. A chemically muted platelet shows up in normal numbers on a blood count but can't release the cargo it was harvested for. You'd pay full price for a preparation that was never going to do anything.
- Aspirin: blocks the pathway for the platelet's entire lifespan, so a one to two week pause is commonly asked for.
- Other non-steroidal painkillers: bind reversibly and clear faster, so a shorter pause usually covers it.
- Fish oil, high-dose vitamin E, garlic, ginkgo, turmeric: small effects on their own, stopped about a week out because people stack several at once.
- Prescribed anticoagulants: only your prescribing doctor decides whether a pause is safe, and if it isn't, the treatment goes rather than the drug.
Aspirin's antiplatelet effect lasts the full lifespan of the platelet, so a pause of one to two weeks is commonly requested, while no prescribed anticoagulant should ever be stopped on a clinic's say-so.
How do blood platelet counts and overall blood health affect eligibility?
Everything that goes into your scalp came out of your arm, so your blood sets the ceiling on what a session can deliver. A baseline count isn't an upsell, it's the only way to know whether the target concentration is even reachable from a standard draw.
A normal adult platelet count sits between 150,000 and 450,000 per microlitre and most protocols target around a million per microlitre in the final volume, so counts below roughly 100,000 are treated as a relative contraindication needing investigation in their own right.
What does a candidacy assessment involve before anyone is approved?
A proper assessment is a diagnostic appointment that happens to end in a treatment decision. If nobody looks at your scalp under magnification and nobody takes a photograph, you're in a sales conversation with a mirror.
- History: when the thinning began, how fast it moved, family pattern on both sides, recent illness, weight loss, childbirth, and current medication.
- Pull test: shows whether you're actively shedding right now or looking at settled pattern loss.
- Magnified scalp imaging: the ratio of thick to fine shafts, hairs per follicular opening, and any redness, scaling or lost openings that point to a scarring process.
- Blood work: full blood count, ferritin, thyroid function and vitamin D, standard where the picture is diffuse or the patient is female.
- Standardised photographs: fixed angles under fixed lighting, taken before anything else happens, because six months later your memory won't be reliable.
A candidacy assessment covers history, a pull test, magnified scalp imaging, blood work including full blood count, ferritin, thyroid function and vitamin D, and standardised baseline photographs taken before the first session.
Can someone with scarring alopecia or an autoimmune hair condition be treated?
These two look almost identical from your side of the mirror and behave nothing alike underneath. In one, the follicle is gone and the ground it stood on has been rebuilt as scar tissue. In the other, the follicle is under attack but the stem cells usually survive, which is why hair can come back on its own years later.
| Scarring alopecia | Patchy autoimmune loss | |
|---|---|---|
| The follicle | Destroyed, replaced by fibrous tissue | Attacked, stem cells usually spared |
| Regrowth potential | None in established areas | Possible, sometimes spontaneous |
| Injections as regrowth | Not a candidate, can aggravate | Modest supporting evidence |
| First step | Scalp biopsy, then anti-inflammatory therapy | Scalp biopsy, then immune-directed therapy |
Established scarring alopecia isn't a candidate for treatment as a regrowth measure because the follicle and its stem cell reservoir have been replaced by fibrous tissue, and any bald patch with redness, scaling or no visible follicular openings needs a diagnosis before a cosmetic course rather than after it.
How does a past or planned hair transplant affect candidacy?
Most people assume a transplant rules them out. It usually does the opposite, because surgery moves resistant follicles into a bare patch and does nothing whatsoever to slow the loss carrying on everywhere else.
- In the weeks before surgery: treatment aims at the condition of both the donor area and the recipient bed.
- During the procedure: some surgeons apply the preparation directly to the grafts to support early survival.
- A short pause afterwards: the grafts seat and the scalp settles before injections start again.
- Around the one to three month mark: injections support recovery and blunt the temporary shedding of transplanted hairs that unsettles nearly everyone.
A transplant history is usually a reason to treat rather than decline, since surgery does nothing to slow ongoing loss in the untreated zones, though poor graft survival caused by surgical technique won't be corrected by injections.
What expectations separate a satisfied patient from a disappointed one?
Satisfaction tracks almost entirely with what you were told at the start, not with what actually grew. Two people can get an identical six-month result, and one is pleased while the other feels cheated. That difference was set in the consultation room, not in the follicle.
- Timeline: nothing meaningful shows before about three months, and an early increase in shedding is common rather than a bad sign.
- Permanence: the hormonal process driving pattern loss isn't switched off, only pushed against, so gains fade once maintenance stops.
- Non-response: a minority of people simply don't respond, and that call gets made after a full initial course against the baseline photographs.
Nothing meaningful shows before about three months, and density has been recorded falling back from its peak at six and twelve months after the last session, which is why maintenance is built into the standard protocols.
Is the cost justified for someone who is only a borderline candidate?
For a borderline candidate the honest answer is usually no, and the arithmetic gets you there faster than any opinion will. This is an open-ended spend with no insurance behind it, set against a gain you might need a magnified comparison to see at all.
| Strong candidate | Borderline candidate | |
|---|---|---|
| Initial course, 3 to 4 sessions | $1,500 to $3,000 | $1,500 to $3,000 |
| Annual maintenance | Several hundred to over $1,000, no end date | Same, no end date |
| Likely visible gain | Density you can see in the mirror | May need magnification to detect |
| Sensible route | Proceed, review after one course | Proven topical or oral first, judge at 6 to 12 months |
An initial course of three to four sessions is commonly quoted between fifteen hundred and three thousand dollars, with maintenance of two or three sessions a year running from several hundred to well over a thousand dollars annually and no end date, and it's almost never covered by insurance because hair loss is classified as cosmetic.
